Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Giorgino

Showing results (1-10 of 258) with videos related to

Pageof 26
Sort By:
Evidence-Based Medicine|July 17, 2014
Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetesFrancesco Giorgino
American Journal of Physiology. Endocrinology and Metabolism|August 27, 2009
Adipose tissue function and dysfunction: organ cross talk and metabolic riskFrancesco Giorgino
Frontiers in Endocrinology|July 16, 2021
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of SemaglutideBaptist Gallwitz, Francesco Giorgino
Diabetes/Metabolism Research and Reviews|May 20, 2020
The diabetic lung: An easy target for SARS-CoV-2?Irene Caruso, Francesco Giorgino
Endocrine|March 13, 2024
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising futureIrene Caruso, Francesco Giorgino
Metabolism: Clinical and Experimental|November 22, 2021
SGLT-2 inhibitors as cardio-renal protective agentsIrene Caruso, Francesco Giorgino
Archives of Physiology and Biochemistry|September 27, 2013
A master course on "Methodologies for bio-medical research in diabetes"Francesco Giorgino, Stefano Del Prato
Advances in Experimental Medicine and Biology|March 30, 2011
Wound healing in diabetes: hemorheological and microcirculatory aspectsGiuseppe Cicco, Francesco Giorgino, Sebastiano Cicco
Annals of the New York Academy of Sciences|February 8, 2013
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trialsFrancesco Giorgino, Anna Leonardini, Luigi Laviola
Trends in Endocrinology and Metabolism: TEM|August 12, 2019
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes TrialsIrene Caruso, Angelo Cignarelli, Francesco Giorgino
Pageof 26

Showing results (1-10 of 258) with videos related to

Sort By:
Pageof 26
Evidence-Based Medicine|July 17, 2014
Intensive glucose-lowering results in increased cardiovascular mortality in younger but not older individuals with type 2 diabetesFrancesco Giorgino
American Journal of Physiology. Endocrinology and Metabolism|August 27, 2009
Adipose tissue function and dysfunction: organ cross talk and metabolic riskFrancesco Giorgino
Frontiers in Endocrinology|July 16, 2021
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of SemaglutideBaptist Gallwitz, Francesco Giorgino
Diabetes/Metabolism Research and Reviews|May 20, 2020
The diabetic lung: An easy target for SARS-CoV-2?Irene Caruso, Francesco Giorgino
Endocrine|March 13, 2024
Renal effects of GLP-1 receptor agonists and tirzepatide in individuals with type 2 diabetes: seeds of a promising futureIrene Caruso, Francesco Giorgino
Metabolism: Clinical and Experimental|November 22, 2021
SGLT-2 inhibitors as cardio-renal protective agentsIrene Caruso, Francesco Giorgino
Archives of Physiology and Biochemistry|September 27, 2013
A master course on "Methodologies for bio-medical research in diabetes"Francesco Giorgino, Stefano Del Prato
Advances in Experimental Medicine and Biology|March 30, 2011
Wound healing in diabetes: hemorheological and microcirculatory aspectsGiuseppe Cicco, Francesco Giorgino, Sebastiano Cicco
Annals of the New York Academy of Sciences|February 8, 2013
Cardiovascular disease and glycemic control in type 2 diabetes: now that the dust is settling from large clinical trialsFrancesco Giorgino, Anna Leonardini, Luigi Laviola
Trends in Endocrinology and Metabolism: TEM|August 12, 2019
Heterogeneity and Similarities in GLP-1 Receptor Agonist Cardiovascular Outcomes TrialsIrene Caruso, Angelo Cignarelli, Francesco Giorgino
Pageof 26